Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer
Completed · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Lung Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether paclitaxel and carboplatin are more effective with or without BMS-275291 for non-small cell lung cancer. PURPOSE: Randomized phase II/III trial to compare the effectiveness of paclitaxel and carboplatin with or without BMS-275291 in treating patients who have advanced or metastatic non-small cell lung cancer.
Key facts
- Study ID
- NCT00006229
- Run by
- NCIC Clinical Trials Group
- People needed
- 774
- Starts
- 2000-04-04
- Expected to finish
- 2009-02-10
- Last updated by the study team
- 2020-04-06
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
- Scripps Clinic — La Jolla, California, United States
- Central Georgia Hematology Oncology, P.C. — Macon, Georgia, United States
- Queen's Medical Center — Honolulu, Hawaii, United States
- Carle Cancer Center — Urbana, Illinois, United States
- Lahey Clinic - Burlington — Burlington, Massachusetts, United States
- Creighton University Cancer Center — Omaha, Nebraska, United States
- Duke University Medical Center — Durham, North Carolina, United States
- University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States
- Erlanger Health Systems — Chattanooga, Tennessee, United States
- Memorial Hospital Cancer Center - Chattanooga — Chattanooga, Tennessee, United States
- Williamson Medical Center — Franklin, Tennessee, United States
- Jackson-Madison County General Hospital — Jackson, Tennessee, United States
- Baptist Regional Cancer Center - Knoxville — Knoxville, Tennessee, United States
- Saint Thomas Hospital — Nashville, Tennessee, United States
- Meharry Medical College — Nashville, Tennessee, United States
- Division of Medical Oncology - Vanderbilt — Nashville, Tennessee, United States
- AKH Vienna — Vienna (Wien), Austria
- Allgemeines Krankenhaus der Stadt Wien — Vienna (Wien), Austria
- Universiteit Gent — Ghent, Belgium
- Centre Hospitalier Regional de la Citadelle — Liege (Luik), Belgium
- Algemeen Ziekenhuis Sint-Augustinus — Wilrijk, Belgium
- Cross Cancer Institute — Edmonton, Alberta, Canada
- CancerCare Manitoba — Winnipeg, Manitoba, Canada
- University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.